This observation might be consistent with the results that mice from nt-KO CD19-CAR-T cell–injected groups showed a trend of faster tumor cell clearance, although with no significant difference compared with mice from ITK-KO CD19-CAR-T cell–injected groups (Supplemental Figure 5F). Here, CD19 is linked to neoplasm.